A study at the Pediatric Psychopharmacology Research Unit, Massachusetts General Hospital, Boston, MA, was completed using OmegaBrite which showed it to be as effective as atypical antipsychotics in rapid reduction of mania in children. OmegaBrite was also used in a study at Ohio State University that showed that OmegaBrite reduces both the perception of stress and the biological indicators of stress in a non-health condition impacted population. OmegaBrite is also being used in several other studies at major medical centers on depression, ADHD and bi-polar disorder in adults and ADHD, depression, bipolar and autism in children.